ICU Medical (ICUI)
ICU Medical Revenues: 75.51M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ICUI Revenues Rankings
| Overall | 42nd percentile | 2547 of 4425 |
| Sector | 65th percentile | 164 of 470 in Healthcare |
| Industry | 67th percentile | 22 of 67 in Medical Instruments & Supplies |
ICUI Revenues Range, Past 5 Years
| Minimum | 44.65M | Mar 2008 |
| Maximum | 77.80M | Jun 2011 |
| Average | 61.68M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these ICUI related companies
ICUI News
$ICUI http://stks.co/3nd4 Continues in a strong UP Trend. Clean break out of Top Box & pulled back. Still closed above the top
about 17 days ago by Fibline
about 17 days ago by Fibline
Patient Protection and Affordable Care Act Will Affect Medical Devices Industry Revenues in 2013
Apr 19, 8:20AM Marketwire
Apr 19, 8:20AM Marketwire
Listen to $ICUI Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3MrS
about 43 days ago by earningscast
about 43 days ago by earningscast
ICU Medical Reports Q1 EPS $0.53 vs $0.48 Est; Revenues $75.5M vs $74.55M Est
Apr 16, 4:01PM Benzinga
Apr 16, 4:01PM Benzinga
$ICUI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3KmD
about 47 days ago by MarketBrief
about 47 days ago by MarketBrief
Benchmark Starts ICU Medical (ICUI) at Buy; Macro Defensive Growth Characteristics
Apr 12, 7:40AM Street Insider
Apr 12, 7:40AM Street Insider
$ICUI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3IZN
about 49 days ago by MarketBrief
about 49 days ago by MarketBrief
$ICUI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3HIk
about 50 days ago by MarketBrief
about 50 days ago by MarketBrief
$ICUI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3GLV
about 51 days ago by MarketBrief
about 51 days ago by MarketBrief
$ICUI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3FXK
about 53 days ago by MarketBrief
about 53 days ago by MarketBrief
$ICUI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3ElO
about 54 days ago by MarketBrief
about 54 days ago by MarketBrief
$ICUI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3Dfz
about 55 days ago by MarketBrief
about 55 days ago by MarketBrief
ICU Medical, Inc. to Present at the Sidoti & Company 16th Annual New York Institutional Investor Forum
Mar 15, 8:15AM GlobeNewswire
Mar 15, 8:15AM GlobeNewswire
URGENT: $ICUI filed to delay releasing annual earnings results (SEC Filing Form NT 10K) http://stks.co/2ryU
about 76 days ago by MarketBrief
about 76 days ago by MarketBrief
Listen to $ICUI Q4 2011 earnings call (EPS 0.7 vs est 0.62) - live at 04:30 PM, ondemand after - http://stks.co/29md
about 120 days ago by earningscast
about 120 days ago by earningscast
$ICUI Guides FY2012 EPS $2.45-2.70 vs $2.69 Est; Revenues $318-330M vs $326.30M Est
about 120 days ago by Benzinga
about 120 days ago by Benzinga
Listen to $ICUI at piper jaffray health care conference - live at 10:30 AM, ondemand after - http://stks.co/1K0q
about 181 days ago by earningscast
about 181 days ago by earningscast
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ICUI | 52.22 | +0.21 | +0.40% | 722.94M |
| ICS | 15.36 | +0.07 | +0.46% | |
| ICON | 15.86 | +0.38 | +2.45% | 1.123B |
| ICLR | 21.90 | -0.03 | -0.14% | 1.319B |
| ICH | 4.11 | -0.05 | -1.20% | 29.91M |
| ICGE | 8.82 | +0.03 | +0.34% | 329.98M |
| IBA | 21.12 | +0.57 | +2.77% | 1.028B |
| IART | 35.59 | +0.30 | +0.85% | 948.60M |
| IAK | 29.77 | +0.26 | +0.88% | |
| IAG | 10.58 | -0.29 | -2.67% | 4.088B |
